Cesca Therapeutics Inc Share Price Nasdaq
Equities
US1571311034
Office Equipment
Sales 2024 * | 16.86M 1.41B | Sales 2025 * | 21.11M 1.76B | Capitalization | 5.52M 460M |
---|---|---|---|---|---|
Net income 2024 * | 2M 167M | Net income 2025 * | 5M 417M | EV / Sales 2024 * | 0.33 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
8.68
x | P/E ratio 2025 * |
3.47
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.89% |
Latest transcript on Cesca Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 10/16/10 |
Jeffery Cauble
DFI | Director of Finance/CFO | 51 | 01/10/01 |
Wendy Samford
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Medford
BRD | Director/Board Member | 69 | 24/17/24 |
Joseph Thomis
BRD | Director/Board Member | 78 | 10/17/10 |
Xiao Chun Xu
CEO | Chief Executive Officer | 53 | 10/16/10 |
1st Jan change | Capi. | |
---|---|---|
+9.51% | 8.32B | |
-4.89% | 4.62B | |
-8.51% | 2.86B | |
+5.40% | 2.18B | |
-25.84% | 1.13B | |
-7.12% | 861M | |
-9.39% | 804M | |
-22.21% | 765M | |
-56.76% | 685M |